avacopan (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Vasculitis

Pending FDA approval for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis including, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome), and microscopic polyangiitis

Next:

Pharmacology

Mechanism of Action

Inhibits complement C5a binding to its receptor, resulting in decreased inflammation

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.